Search Results - "Dionellis, Vasilis S."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits by Rossetti, Giacomo G., Ossorio, Marianna A., Rempel, Stephan, Kratzel, Annika, Dionellis, Vasilis S., Barriot, Samia, Tropia, Laurence, Gorgulla, Christoph, Arthanari, Haribabu, Thiel, Volker, Mohr, Peter, Gamboni, Remo, Halazonetis, Thanos D.

    Published in Scientific reports (15-02-2022)
    “…M pro , the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is essential for the viral life cycle. Accordingly, several…”
    Get full text
    Journal Article
  2. 2

    Genome Sequencing of five Lacticaseibacillus Strains and Analysis of Type I and II Toxin-Antitoxin System Distribution by Levante, Alessia, Lazzi, Camilla, Vatsellas, Giannis, Chatzopoulos, Dimitris, Dionellis, Vasilis S, Makrythanasis, Periklis, Neviani, Erasmo, Folli, Claudia

    Published in Microorganisms (Basel) (21-03-2021)
    “…The analysis of bacterial genomes is a potent tool to investigate the distribution of specific traits related to the ability of surviving in particular…”
    Get full text
    Journal Article
  3. 3

    Enhanced Rate of Acquisition of Point Mutations in Mouse Intestinal Adenomas Compared to Normal Tissue by Lugli, Natalia, Dionellis, Vasilis S., Ordóñez-Morán, Paloma, Kamileri, Irene, Sotiriou, Sotirios K., Huelsken, Joerg, Halazonetis, Thanos D.

    Published in Cell reports (Cambridge) (13-06-2017)
    “…The most prevalent single-nucleotide substitution (SNS) found in cancers is a C-to-T substitution in the CpG motif. It has been proposed that many of these…”
    Get full text
    Journal Article
  4. 4

    Transcription–replication conflicts underlie sensitivity to PARP inhibitors by Petropoulos, Michalis, Karamichali, Angeliki, Rossetti, Giacomo G., Freudenmann, Alena, Iacovino, Luca G., Dionellis, Vasilis S., Sotiriou, Sotirios K., Halazonetis, Thanos D.

    Published in Nature (London) (11-04-2024)
    “…An important advance in cancer therapy has been the development of poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of homologous recombination…”
    Get full text
    Journal Article
  5. 5

    Non-covalent SARS-CoV-2 M pro inhibitors developed from in silico screen hits by Rossetti, Giacomo G, Ossorio, Marianna A, Rempel, Stephan, Kratzel, Annika, Dionellis, Vasilis S, Barriot, Samia, Tropia, Laurence, Gorgulla, Christoph, Arthanari, Haribabu, Thiel, Volker, Mohr, Peter, Gamboni, Remo, Halazonetis, Thanos D

    Published in Scientific reports (15-02-2022)
    “…M , the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is essential for the viral life cycle. Accordingly, several groups…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes by Dionellis, Vasilis S, Norkin, Maxim, Karamichali, Angeliki, Rossetti, Giacomo G, Huelsken, Joerg, Ordonez-Moran, Paloma, Halazonetis, Thanos D

    Published in Cancers (12-03-2021)
    “…The genomes of many human CRCs have been sequenced, revealing a large number of genetic alterations. However, the molecular mechanisms underlying the…”
    Get full text
    Journal Article
  10. 10

    Notch controls urothelial integrity in the mouse bladder by Paraskevopoulou, Varvara, Bonis, Vangelis, Dionellis, Vasilis S, Paschalidis, Nikolaos, Melissa, Pelagia, Chavdoula, Evangelia, Vasilaki, Eleni, Pateras, Ioannis S, Klinakis, Apostolos

    Published in JCI insight (13-02-2020)
    “…The Notch signaling pathway mediates cell-cell communication regulating cell differentiation and proliferation and cell fate decisions in various tissues. In…”
    Get full text
    Journal Article